|
1
|
Siegel R, Desantis C, Virgo K, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prockop DJ: Marrow stromal cells as stem
cells for nonhematopoietic tissues. Science. 276:71–74. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Young HE, Steele TA, Bray RA, et al: Human
reserve pluripotent mesenchymal stem cells are present in the
connective tissues of skeletal muscle and dermis derived from
fetal, adult, and geriatric donors. Anat Rec (Hoboken). 264:51–62.
2001. View
Article : Google Scholar
|
|
4
|
Pittenger MF, Mackay AM, Beck SC, et al:
Multilineage potential of adult human mesenchymal stem cells.
Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Young HE, Duplaa C, Young TM, et al:
Clonogenic analysis reveals reserve stem cells in postnatal
mammals: I. Pluripotent mesenchymal stem cells. Anat Rec (Hoboken).
263:350–360. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fox JM, Chamberlain G, Ashton BA and
Middleton J: Recent advances into the understanding of mesenchymal
stem cell trafficking. Br J Haematol. 137:491–502. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Karnoub AE, Dash AB, Vo AP, et al:
Mesenchymal stem cells within tumour stroma promote breast cancer
metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mishra PJ, Humeniuk R, Medina DJ, et al:
Carcinoma-associated fibroblast-like differentiation of human
mesenchymal stem cells. Cancer Res. 68:4331–4339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Studeny M, Marini FC, Champlin RE,
Zompetta C, Fidler IJ and Andreeff M: Bone marrow-derived
mesenchymal stem cells as vehicles for interferon-beta delivery
into tumors. Cancer Res. 62:3603–3608. 2002.PubMed/NCBI
|
|
10
|
Xin H, Kanehira M, Mizuguchi H, et al:
Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal
stem cells. Stem Cells. 25:1618–1626. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stagg J: Mesenchymal stem cells in cancer.
Stem Cell Rev. 4:119–124. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang W: Mesenchymal stem cells in cancer:
friends or foes. Cancer Biol Ther. 7:252–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bian ZY, Fan QM, Li G, Xu WT and Tang TT:
Human mesenchymal stem cells promote growth of osteosarcoma:
involvement of interleukin-6 in the interaction between human
mesenchymal stem cells and Saos-2. Cancer Sci. 101:2554–2560. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bagley RG, Weber W, Rouleau C, et al:
Human mesenchymal stem cells from bone marrow express tumor
endothelial and stromal markers. Int J Oncol. 34:619–627. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kato K, Ogura T, Kishimoto A, et al:
Critical roles of AMP-activated protein kinase in constitutive
tolerance of cancer cells to nutrient deprivation and tumor
formation. Oncogene. 21:6082–6090. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Iglehart JD, Richardson AL and Wang
ZC: The amplified cancer gene LAPTM4B promotes tumor growth and
tolerance to stress through the induction of autophagy. Autophagy.
8:273–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kelekar A: Introduction to the review
series Autophagy in Higher Eukaryotes--a matter of survival or
death. Autophagy. 4:555–556. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yin L, Kharbanda S and Kufe D: MUC1
oncoprotein promotes autophagy in a survival response to glucose
deprivation. Int J Oncol. 34:1691–1699. 2009.PubMed/NCBI
|
|
19
|
Carew JS, Medina EC, Esquivel JA II, et
al: Autophagy inhibition enhances vorinostat-induced apoptosis via
ubiquitinated protein accumulation. J Cell Mol Med. 14:2448–2459.
2010. View Article : Google Scholar
|
|
20
|
Kang C, You YJ and Avery L: Dual roles of
autophagy in the survival of Caenorhabditis elegans during
starvation. Genes Dev. 21:2161–2171. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nature reviews Cancer. 7:961–967.
2007. View
Article : Google Scholar
|
|
22
|
Fujii S, Mitsunaga S, Yamazaki M, et al:
Autophagy is activated in pancreatic cancer cells and correlates
with poor patient outcome. Cancer Sci. 99:1813–1819.
2008.PubMed/NCBI
|
|
23
|
Dominici M, Le Blanc K, Mueller I, et al:
Minimal criteria for defining multipotent mesenchymal stromal
cells. The International Society for Cellular Therapy position
statement. Cytotherapy. 8:315–317. 2006. View Article : Google Scholar
|
|
24
|
Rhodes LV, Muir SE, Elliott S, et al:
Adult human mesenchymal stem cells enhance breast tumorigenesis and
promote hormone independence. Breast Cancer Res Treat. 121:293–300.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Klionsky DJ, Abeliovich H, Agostinis P, et
al: Guidelines for the use and interpretation of assays for
monitoring autophagy in higher eukaryotes. Autophagy. 4:151–175.
2008. View Article : Google Scholar
|
|
26
|
Seglen PO and Gordon PB: 3-Methyladenine:
specific inhibitor of autophagic/lysosomal protein degradation in
isolated rat hepatocytes. Proc Natl Acad Sci USA. 79:1889–1892.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sanchez CG, Penfornis P, Oskowitz AZ, et
al: Activation of autophagy in mesenchymal stem cells provides
tumor stromal support. Carcinogenesis. 32:964–972. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Degenhardt K, Mathew R, Beaudoin B, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Karantza-Wadsworth V and White E: Role of
autophagy in breast cancer. Autophagy. 3:610–613. 2007. View Article : Google Scholar
|
|
30
|
Lum JJ, Bauer DE, Kong M, et al: Growth
factor regulation of autophagy and cell survival in the absence of
apoptosis. Cell. 120:237–248. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karantza-Wadsworth V, Patel S, Kravchuk O,
et al: Autophagy mitigates metabolic stress and genome damage in
mammary tumorigenesis. Genes Dev. 21:1621–1635. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Boya P, Gonzalez-Polo RA, Casares N, et
al: Inhibition of macro-autophagy triggers apoptosis. Mol Cell
Biol. 25:1025–1040. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Roorda BD, ter Elst A, Kamps WA and de
Bont ES: Bone marrow-derived cells and tumor growth: contribution
of bone marrow-derived cells to tumor micro-environments with
special focus on mesenchymal stem cells. Crit Rev Oncol Hematol.
69:187–198. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tian LL, Yue W, Zhu F, Li S and Li W:
Human mesenchymal stem cells play a dual role on tumor cell growth
in vitro and in vivo. J Cell Physiol. 226:1860–1867. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sinha S and Levine B: The autophagy
effector Beclin 1: a novel BH3-only protein. Oncogene. 27(Suppl 1):
S137–S148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maiuri MC, Criollo A, Tasdemir E, et al:
BH3-only proteins and BH3 mimetics induce autophagy by
competitively disrupting the interaction between Beclin 1 and
Bcl-2/Bcl-X(L). Autophagy. 3:374–376. 2007. View Article : Google Scholar
|
|
37
|
Pattingre S, Tassa A, Qu X, et al: Bcl-2
antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell.
122:927–939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chang NC, Nguyen M, Germain M and Shore
GC: Antagonism of Beclin 1-dependent autophagy by BCL-2 at the
endoplasmic reticulum requires NAF-1. EMBO J. 29:606–618. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lian J, Wu X, He F, et al: A natural BH3
mimetic induces autophagy in apoptosis-resistant prostate cancer
via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum.
Cell Death Differ. 18:60–71. 2011. View Article : Google Scholar : PubMed/NCBI
|
